import sys
sys.path.append('.')  # NOQA

import molecularmatch_trials
import json
from collections import namedtuple
import evidence_label as el


EVIDENCE = json.loads("""
{"status": "Recruiting", "startDate": "June 2016", "title": "Hyperpolarized Xenon-129 Functional Magnetic Resonance Imaging of Healthy Volunteers and Participants With Alzheimer's Disease", "molecularAlterations": [], "_score": -7, "interventions": [{"intervention_name": "Traditional Proton fMRI", "description": "Conventional proton fMRI will be performed. During the functional imaging acquisitions, the participant will be asked by the research team to perform simple tasks. These tasks will be completed while the participant breathes air (normal breathing).", "arm_group_label": ["Healthy Volunteers", "Alzheimer's Disease Participants"], "intervention_type": "Other"}, {"intervention_name": "Hyperpolarized Xenon-129 fMRI", "other_name": "HP 129Xe fMRI", "description": "HP 129Xe fMRI data will be acquired from all participants. Hyperpolarized xenon (NeuroXene) is expected to produce images that provide more clinically relevant information than traditional proton scans. Simple tasks will be performed by participants while breathing NeuroXene according to several inhalation procedures.", "arm_group_label": ["Healthy Volunteers", "Alzheimer's Disease Participants"], "intervention_type": "Other"}, {"intervention_name": "Hyperpolarized Xenon-129", "other_name": "NeuroXene", "description": "Participants will be asked to inhale specified amounts of NeuroXene according to several inhalation procedures. NeuroXene is the trade name for hyperpolarization of xenon-129 balanced with oxygen and nitrogen using a Xemed LLC polarizer. Hyperpolarization does not change the chemical or physical properties of xenon gas.", "arm_group_label": ["Healthy Volunteers", "Alzheimer's Disease Participants"], "intervention_type": "Drug"}, {"intervention_name": "1H-129Xe Dual-Tuned Quadrature Head Coil", "description": "A 1H-129Xe dual-tuned quadrature head coil (Clinical MR Solutions, LLC) will be used in this study. The RF coil will be used to acquire MRI images of the human brain after inhalation of hyperpolarized xenon-129 gas, and permits the acquisition of both conventional proton and HP xenon gas images.", "arm_group_label": ["Healthy Volunteers", "Alzheimer's Disease Participants"], "intervention_type": "Device"}], "locations": [{"status": "Recruiting", "city": "Thunder Bay", "last_name": "Mitchell S Albert, PhD", "phone_backup": "807-684-6958", "zip": "P7B 6V4", "country": "Canada", "last_name_backup": "Jennifer Plata, HBSc", "email": "albertmi@tbh.net", "phone": "807-684-7270", "state": "Ontario", "email_backup": "plataj@tbh.net", "geo": {"lat": 48.416, "lon": -89.267}, "id": "thunderbayregionalhealthsciencescentre_thunderbay_ontario_ca_p7b6v4", "name": "Thunder Bay Regional Health Sciences Centre"}], "briefTitle": "HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease", "overallContact": {"phone": "807-684-7270", "last_name": "Mitchell Albert, Ph.D.", "email": "albertmi@tbh.net"}, "phase": "Early Phase 1", "tags": [{"facet": "DRUG", "compositeKey": "Oxygen compressedDRUGinclude", "suppress": false, "filterType": "include", "term": "Oxygen compressed", "custom": false, "priority": 1, "alias": "Oxygen compressed"}, {"facet": "DRUG", "compositeKey": "NitrogenDRUGinclude", "suppress": false, "filterType": "include", "term": "Nitrogen", "custom": false, "priority": 1, "alias": "Nirtogen"}, {"facet": "DRUG", "compositeKey": "Xenon xe-133DRUGinclude", "suppress": false, "filterType": "include", "term": "Xenon xe-133", "custom": false, "priority": 1, "alias": "Xenon xe-133"}, {"facet": "DRUGCLASS", "compositeKey": "Inhalation Diagnostic AgentDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Inhalation Diagnostic Agent", "custom": false, "priority": 0, "alias": "Inhalation Diagnostic Agent", "generatedByTerm": "Xenon xe-133"}, {"facet": "DRUGCLASS", "compositeKey": "Radiopharmaceutical ActivityDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Radiopharmaceutical Activity", "custom": false, "priority": 0, "alias": "Radiopharmaceutical Activity", "generatedByTerm": "Xenon xe-133"}, {"facet": "DRUG", "compositeKey": "NirtogenDRUGinclude", "suppress": false, "filterType": "include", "term": "Nirtogen", "custom": false, "priority": 1, "alias": "Nirtogen"}, {"facet": "CONDITION", "compositeKey": "DementiaCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Dementia", "custom": false, "priority": 1, "alias": "Dementia"}, {"facet": "CONDITION", "compositeKey": "Infective disorderCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Infective disorder", "custom": false, "priority": 1, "alias": "Infection"}, {"facet": "PHASE", "compositeKey": "Phase 1PHASEinclude", "suppress": false, "filterType": "include", "term": "Phase 1", "custom": false, "priority": 1, "alias": "Phase 1"}, {"facet": "CONDITION", "compositeKey": "AD - Alzheimer's diseaseCONDITIONinclude", "suppress": false, "filterType": "include", "term": "AD - Alzheimer's disease", "custom": false, "priority": 1, "alias": "AD - Alzheimer's disease"}, {"facet": "SITE", "compositeKey": "CerebralSITEinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Cerebral", "custom": false, "priority": 0, "alias": "Cerebral", "generatedByTerm": "AD - Alzheimer's disease"}, {"facet": "FINDING", "compositeKey": "Pregnancy confirmedFINDINGexclude", "suppress": false, "filterType": "exclude", "term": "Pregnancy confirmed", "custom": false, "priority": 1, "alias": "Pregnant"}, {"facet": "GENE", "compositeKey": "HPGENEinclude", "suppress": false, "filterType": "include", "term": "HP", "custom": false, "priority": 1, "alias": "HP"}, {"facet": "GENE", "compositeKey": "PTPRFGENEinclude", "suppress": false, "filterType": "include", "term": "PTPRF", "custom": false, "priority": 2, "alias": "PTPRF"}, {"facet": "STATUS", "compositeKey": "RecruitingSTATUSinclude", "suppress": false, "filterType": "include", "term": "Recruiting", "custom": false, "priority": 1, "alias": "Recruiting"}, {"facet": "TRIALTYPE", "compositeKey": "DiagnosticTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Diagnostic", "custom": false, "priority": 1, "alias": "Diagnostic"}, {"facet": "TRIALTYPE", "compositeKey": "InterventionalTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Interventional", "custom": false, "priority": 1, "alias": "Interventional"}], "id": "NCT02638519", "studyType": "Interventional"}
""")  # NOQA


PHENOTYPE = json.loads("""
{"status": "Recruiting", "startDate": "April 2016", "interventions": [{"intervention_name": "Trabectedin", "arm_group_label": "Trabectedin", "other_name": "Yondelis", "intervention_type": "Drug"}, {"intervention_name": "Pegylated Liposomal Doxorubicin", "arm_group_label": "Standard Treatment", "intervention_type": "Drug"}, {"intervention_name": "Topotecan", "arm_group_label": "Standard Treatment", "intervention_type": "Drug"}, {"intervention_name": "Gemcitabine", "arm_group_label": "Standard Treatment", "intervention_type": "Drug"}, {"intervention_name": "Weekly Paclitaxel", "arm_group_label": "Standard Treatment", "intervention_type": "Drug"}, {"intervention_name": "Carboplatin", "arm_group_label": "Standard Treatment", "intervention_type": "Drug"}], "molecularAlterations": [], "_score": 24, "title": "Randomized Phase III Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype patients_MITO-23", "locations": [{"status": "Recruiting", "city": "Milan", "last_name": "Domenica Lorusso, MD", "phone_backup": "+390223903818", "zip": "20133", "created": "2016-09-18T00:42:50.831Z", "_validMessage": "geocoder failed", "country": "Italy", "last_name_backup": "Elisa Grassi", "lastUpdated": "2017-12-29T12:51:07.590Z", "email": "domenica.lorusso@istitutotumori.mi.it", "phone": "+390223903697", "state": "", "failedGeocode": true, "email_backup": "elisa.grassi@istitutotumori.mi.it", "id": "domenicalorusso_milan_it_20133", "_valid": false, "name": "Domenica Lorusso"}], "briefTitle": "Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23", "overallContact": {"phone": "+390223903697", "last_name": "Domenica Lorusso, MD", "email": "domenica.lorusso@istitutotumori.mi.it"}, "link": "http://clinicaltrials.gov/ct2/show/NCT02903004", "studyType": "Interventional", "phase": "Phase 3", "id": "NCT02903004", "tags": [{"priority": 1, "compositeKey": "Ovarian CaCONDITIONinclude", "suppress": false, "generatedBy": "", "filterType": "include", "term": "Ovarian Ca", "custom": true, "facet": "CONDITION", "alias": "Ovarian cancer", "manualSuppress": 0, "generatedByTerm": ""}, {"priority": 1, "compositeKey": "Carcinoma of ovaryCONDITIONinclude", "suppress": false, "generatedBy": "", "filterType": "include", "term": "Carcinoma of ovary", "custom": true, "facet": "CONDITION", "alias": "Carcinoma of ovary", "manualSuppress": 0, "generatedByTerm": ""}, {"priority": 1, "compositeKey": "Carcinoma of peritoneumCONDITIONinclude", "suppress": false, "generatedBy": "", "filterType": "include", "term": "Carcinoma of peritoneum", "custom": true, "facet": "CONDITION", "alias": "Primary Peritoneal Carcinoma", "manualSuppress": 0, "generatedByTerm": ""}, {"priority": 1, "compositeKey": "Tumour of fallopian tubeCONDITIONinclude", "suppress": false, "generatedBy": "", "filterType": "include", "term": "Tumour of fallopian tube", "custom": true, "facet": "CONDITION", "alias": "Fallopian tube cancer", "manualSuppress": 0, "generatedByTerm": ""}, {"priority": 2, "compositeKey": "PARP1GENEinclude", "suppress": false, "filterType": "include", "term": "PARP1", "custom": false, "facet": "GENE", "alias": "PARP1", "manualSuppress": 0}, {"priority": 3, "compositeKey": "BRCA1GENEinclude", "manualPriority": 3, "suppress": false, "filterType": "include", "term": "BRCA1", "custom": false, "facet": "GENE", "alias": "BRCA1", "manualSuppress": 0}, {"priority": 3, "compositeKey": "BRCAGENEinclude", "manualPriority": 3, "suppress": false, "filterType": "include", "term": "BRCA", "custom": false, "facet": "GENE", "alias": "BRCA", "manualSuppress": 0}, {"priority": 3, "compositeKey": "BRCA2GENEinclude", "manualPriority": 3, "suppress": false, "filterType": "include", "term": "BRCA2", "custom": false, "facet": "GENE", "alias": "BRCA2", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Infective disorderCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Infective disorder", "custom": false, "facet": "CONDITION", "alias": "Infection", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Carcinoma of cervixCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Carcinoma of cervix", "custom": false, "facet": "CONDITION", "alias": "Carcinoma of cervix", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Platinum-based Drug resistanceRESISTANCEinclude", "suppress": false, "generatedBy": "DRUGCLASS", "filterType": "include", "term": "Platinum-based Drug resistance", "custom": false, "facet": "RESISTANCE", "alias": "Platinum-based Drug resistance", "manualSuppress": 0, "generatedByTerm": "Platinum-based Drug"}, {"priority": 1, "compositeKey": "Congestive cardiac failureCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Congestive cardiac failure", "custom": false, "facet": "CONDITION", "alias": "Congestive cardiac failure", "manualSuppress": 0}, {"priority": 1, "compositeKey": "MI - Myocardial infarctionCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "MI - Myocardial infarction", "custom": false, "facet": "CONDITION", "alias": "Heart attack", "manualSuppress": 0}, {"priority": 1, "compositeKey": "HF - Heart failureCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "HF - Heart failure", "custom": false, "facet": "CONDITION", "alias": "Heart failure", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Carcinoma in situCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Carcinoma in situ", "custom": false, "facet": "CONDITION", "alias": "Carcinoma in situ", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Secondary malignant neoplastic diseaseCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Secondary malignant neoplastic disease", "custom": false, "facet": "CONDITION", "alias": "Metastases", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Gemcitabine hydrochlorideDRUGinclude", "suppress": false, "filterType": "include", "term": "Gemcitabine hydrochloride", "custom": false, "facet": "DRUG", "alias": "Gemcitabine hydrochloride", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Nucleic Acid Synthesis InhibitorsDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Nucleic Acid Synthesis Inhibitors", "custom": false, "facet": "DRUGCLASS", "alias": "Nucleic Acid Synthesis Inhibitors", "manualSuppress": 0, "generatedByTerm": "Gemcitabine hydrochloride"}, {"priority": 0, "compositeKey": "Nucleoside Metabolic InhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Nucleoside Metabolic Inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Nucleoside Metabolic Inhibitor", "generatedByTerm": "Gemcitabine hydrochloride"}, {"priority": 0, "compositeKey": "AdjuvantDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Adjuvant", "custom": false, "facet": "DRUGCLASS", "alias": "Adjuvant", "manualSuppress": 0, "generatedByTerm": "Paclitaxel"}, {"priority": 0, "compositeKey": "ChemotherapyDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Chemotherapy", "custom": false, "facet": "DRUGCLASS", "alias": "Chemotherapy", "manualSuppress": 0, "generatedByTerm": "Trabectedin"}, {"priority": 2, "compositeKey": "MUC16GENEinclude", "suppress": false, "filterType": "include", "term": "MUC16", "custom": false, "facet": "GENE", "alias": "CA-125", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Phase 3PHASEinclude", "suppress": false, "filterType": "include", "term": "Phase 3", "custom": false, "facet": "PHASE", "alias": "Phase 3", "manualSuppress": 0}, {"priority": 1, "compositeKey": "RecruitingSTATUSinclude", "suppress": false, "filterType": "include", "term": "Recruiting", "custom": false, "facet": "STATUS", "alias": "Recruiting", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Doxorubicin hydrochlorideDRUGinclude", "suppress": false, "filterType": "include", "term": "Doxorubicin hydrochloride", "custom": false, "facet": "DRUG", "alias": "Doxorubicin hydrochloride", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Topoisomerase InhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Topoisomerase Inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Topoisomerase Inhibitor", "generatedByTerm": "Topotecan hydrochloride"}, {"priority": 0, "compositeKey": "TOP1 inhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "TOP1 inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "TOP1 inhibitor", "generatedByTerm": "Topotecan hydrochloride"}, {"priority": 0, "compositeKey": "Topoisomerase inhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Topoisomerase inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Topoisomerase Inhibitor", "manualSuppress": 0, "generatedByTerm": "Topotecan hydrochloride"}, {"priority": 0, "compositeKey": "Topoisomerase InhibitorsDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Topoisomerase Inhibitors", "custom": false, "facet": "DRUGCLASS", "alias": "Topoisomerase Inhibitors", "generatedByTerm": "Topotecan hydrochloride"}, {"priority": 0, "compositeKey": "Vinca AlkaloidDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Vinca Alkaloid", "custom": false, "facet": "DRUGCLASS", "alias": "Vinca Alkaloid", "manualSuppress": 0, "generatedByTerm": "Doxorubicin hydrochloride"}, {"priority": 0, "compositeKey": "Anthracycline Topoisomerase InhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Anthracycline Topoisomerase Inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Anthracycline Topoisomerase Inhibitor", "generatedByTerm": "Doxorubicin hydrochloride"}, {"priority": 1, "compositeKey": "Topotecan hydrochlorideDRUGinclude", "suppress": false, "filterType": "include", "term": "Topotecan hydrochloride", "custom": false, "facet": "DRUG", "alias": "Topotecan hydrochloride", "manualSuppress": 0}, {"priority": 1, "compositeKey": "PaclitaxelDRUGinclude", "suppress": false, "filterType": "include", "term": "Paclitaxel", "custom": false, "facet": "DRUG", "alias": "Paclitaxel", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Microtubule InhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Microtubule Inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Microtubule Inhibitor", "generatedByTerm": "Paclitaxel"}, {"priority": 0, "compositeKey": "Microtubule inhibitorDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Microtubule inhibitor", "custom": false, "facet": "DRUGCLASS", "alias": "Microtubule inhibitor", "manualSuppress": 0, "generatedByTerm": "Paclitaxel"}, {"priority": 1, "compositeKey": "CarboplatinDRUGinclude", "suppress": false, "filterType": "include", "term": "Carboplatin", "custom": false, "facet": "DRUG", "alias": "Carboplatin", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Superficial basal cell carcinomaCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Superficial basal cell carcinoma", "custom": false, "facet": "CONDITION", "alias": "Basal cell carcinoma", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Jns002DRUGinclude", "suppress": false, "filterType": "include", "term": "Jns002", "custom": false, "facet": "DRUG", "alias": "Jns002", "manualSuppress": 0}, {"priority": 1, "compositeKey": "TrabectedinDRUGinclude", "suppress": false, "filterType": "include", "term": "Trabectedin", "custom": false, "facet": "DRUG", "alias": "Yondelis", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Alkylating DrugDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Alkylating Drug", "custom": false, "facet": "DRUGCLASS", "alias": "Alkylating Drug", "generatedByTerm": "Trabectedin"}, {"priority": 1, "compositeKey": "RandomizedTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Randomized", "custom": false, "facet": "TRIALTYPE", "alias": "Randomized", "manualSuppress": 0}, {"priority": 1, "compositeKey": "InterventionalTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Interventional", "custom": false, "facet": "TRIALTYPE", "alias": "Interventional", "manualSuppress": 0}, {"priority": 1, "compositeKey": "Carcinoma, NOSCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Carcinoma, NOS", "custom": false, "facet": "CONDITION", "alias": "carcinoma of unknown primary site", "manualSuppress": 0}, {"priority": 1, "compositeKey": "DexamethasoneDRUGexclude", "suppress": false, "filterType": "exclude", "term": "Dexamethasone", "custom": false, "facet": "DRUG", "alias": "Dexamethasone", "manualSuppress": 0}, {"priority": 0, "compositeKey": "Malignant tumor of abdomenCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant tumor of abdomen", "custom": false, "facet": "CONDITION", "alias": "Malignant tumor of abdomen", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant tumor of soft tissue of abdomenCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant tumor of soft tissue of abdomen", "custom": false, "facet": "CONDITION", "alias": "Malignant tumor of soft tissue of abdomen", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Neoplasm of the peritoneumCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of the peritoneum", "custom": false, "facet": "CONDITION", "alias": "Neoplasm of the peritoneum", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Malignant neoplastic diseaseCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant neoplastic disease", "custom": false, "facet": "CONDITION", "alias": "Cancer", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Peritoneal cancerCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Peritoneal cancer", "custom": false, "facet": "CONDITION", "alias": "Peritoneal cancer", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Neoplasm of soft tissues of abdomenCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of soft tissues of abdomen", "custom": false, "facet": "CONDITION", "alias": "Neoplasm of soft tissues of abdomen", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Neoplasm of soft tissueCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of soft tissue", "custom": false, "facet": "CONDITION", "alias": "Soft tissues cancer", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Neoplasm of connective tissuesCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of connective tissues", "custom": false, "facet": "CONDITION", "alias": "Connective tissue cancer", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Neoplasm of soft tissues of trunkCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of soft tissues of trunk", "custom": false, "facet": "CONDITION", "alias": "Neoplasm of soft tissues of trunk", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "NeoplasiaCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasia", "custom": false, "facet": "CONDITION", "alias": "Neoplasia", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant tumour of soft tissueCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant tumour of soft tissue", "custom": false, "facet": "CONDITION", "alias": "Malignant tumour of soft tissue", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Solid tumorCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Solid tumor", "custom": false, "facet": "CONDITION", "alias": "Solid tumor", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "PeritoneumSITEinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Peritoneum", "custom": false, "facet": "SITE", "alias": "Peritoneum", "manualSuppress": 0, "generatedByTerm": "Carcinoma of peritoneum"}, {"priority": 0, "compositeKey": "Malignant neoplasm of genital structureCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant neoplasm of genital structure", "custom": false, "facet": "CONDITION", "alias": "Malignant neoplasm of genital structure", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Tumour of ovaryCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Tumour of ovary", "custom": false, "facet": "CONDITION", "alias": "Tumour of ovary", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant tumor of pelvisCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant tumor of pelvis", "custom": false, "facet": "CONDITION", "alias": "Malignant tumor of pelvis", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Neoplasm of uterine adnexaCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasm of uterine adnexa", "custom": false, "facet": "CONDITION", "alias": "Uterine adnexa cancer", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant neoplasm of uterine adnexaCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant neoplasm of uterine adnexa", "custom": false, "facet": "CONDITION", "alias": "Malignant neoplasm of uterine adnexa", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant tumour of female genital organCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant tumour of female genital organ", "custom": false, "facet": "CONDITION", "alias": "Malignant tumour of female genital organ", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Malignant neoplasm of genitourinary organCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant neoplasm of genitourinary organ", "custom": false, "facet": "CONDITION", "alias": "Malignant neoplasm of genitourinary organ", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "OvarySITEinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Ovary", "custom": false, "facet": "SITE", "alias": "Ovary", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}, {"priority": 0, "compositeKey": "Salpinx uterinaSITEinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Salpinx uterina", "custom": false, "facet": "SITE", "alias": "Salpinx uterina", "manualSuppress": 0, "generatedByTerm": "Tumour of fallopian tube"}, {"priority": 0, "compositeKey": "Epithelial tumour of ovaryCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Epithelial tumour of ovary", "custom": false, "facet": "CONDITION", "alias": "Epithelial tumour of ovary", "manualSuppress": 0, "generatedByTerm": "Carcinoma of ovary"}]}
""")  # NOQA

phenotype2 = """
{"status": "Unknown status", "startDate": "August 2009", "interventions": [{"intervention_name": "endostar and CHOP", "arm_group_label": "treatment", "description": "endostar, 7.5m g/m2, intravenous, Day 2-15, repeat every 3 weeks CHOP: Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone", "other_name": "endostar", "intervention_type": "Drug"}], "molecularAlterations": [], "_score": 18, "title": "Phase 2 Study of Endostar Combined With CHOP Regimen as the First Line Chemotherapy for Untreated Peripheral T Cell Lymphoma", "locations": [{"status": "Recruiting", "city": "Shanghai", "last_name": "Haiyi Guo, MD", "_valid": true, "zip": "200032", "country": "China", "id": "fudanuniversitycancerhospital_shanghai_shanghai_cn_200032", "phone": "86(021)64175590", "state": "Shanghai", "location": {"type": "Point", "coordinates": [121.474, 31.23]}, "phone_ext": "5008", "geo": {"lat": 31.23, "lon": 121.474}, "email": "guohaiyi@csco.org.cn", "name": "Fudan University Cancer Hospital"}], "briefTitle": "Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma", "overallContact": {"phone": "86(021)64175590", "last_name": "Haiyi Guo, MD", "email": "guohaiyi@csco.org.cn", "phone_ext": "5008"}, "link": "http://clinicaltrials.gov/ct2/show/NCT00974324", "studyType": "Interventional", "phase": "Phase 2", "id": "NCT00974324", "tags": [{"priority": 2, "compositeKey": "ALKGENEinclude", "suppress": false, "filterType": "include", "term": "ALK", "custom": false, "facet": "GENE", "alias": "ALK"}, {"priority": 0, "compositeKey": "Lymphoreticular tumourCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Lymphoreticular tumour", "custom": false, "facet": "CONDITION", "alias": "Lymphoreticular tumour", "generatedByTerm": "Malignant lymphoma"}, {"priority": 0, "compositeKey": "Hematologic malignancyCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Hematologic malignancy", "custom": false, "facet": "CONDITION", "alias": "Hematologic malignancy", "generatedByTerm": "Malignant lymphoma"}, {"priority": 0, "compositeKey": "Malignant neoplastic diseaseCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Malignant neoplastic disease", "custom": false, "facet": "CONDITION", "alias": "Cancer", "generatedByTerm": "Malignant lymphoma"}, {"priority": 0, "compositeKey": "Lymphoproliferative disorderCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Lymphoproliferative disorder", "custom": false, "facet": "CONDITION", "alias": "Lymphoproliferative disorder", "generatedByTerm": "Malignant lymphoma"}, {"priority": 0, "compositeKey": "NeoplasiaCONDITIONinclude", "suppress": false, "generatedBy": "CONDITION", "filterType": "include", "term": "Neoplasia", "custom": false, "facet": "CONDITION", "alias": "Neoplasia", "generatedByTerm": "Malignant lymphoma"}, {"priority": 1, "compositeKey": "Normal breast feedingFINDINGexclude", "suppress": false, "filterType": "exclude", "term": "Normal breast feeding", "custom": false, "facet": "FINDING", "alias": "Breast feeding"}, {"priority": 1, "compositeKey": "Pregnancy confirmedFINDINGexclude", "suppress": false, "filterType": "exclude", "term": "Pregnancy confirmed", "custom": false, "facet": "FINDING", "alias": "Pregnant"}, {"priority": 1, "compositeKey": "VEGFGENEinclude", "suppress": false, "filterType": "include", "term": "VEGF", "custom": false, "facet": "GENE", "alias": "Vascular endothelial growth factor"}, {"priority": 1, "compositeKey": "Congestive cardiac failureCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Congestive cardiac failure", "custom": false, "facet": "CONDITION", "alias": "Congestive cardiac failure"}, {"priority": 1, "compositeKey": "MI - Myocardial infarctionCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "MI - Myocardial infarction", "custom": false, "facet": "CONDITION", "alias": "Heart attack"}, {"priority": 1, "compositeKey": "HF - Heart failureCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "HF - Heart failure", "custom": false, "facet": "CONDITION", "alias": "Heart failure"}, {"priority": 1, "compositeKey": "Phase 2PHASEinclude", "suppress": false, "filterType": "include", "term": "Phase 2", "custom": false, "facet": "PHASE", "alias": "Phase 2"}, {"priority": 1, "compositeKey": "EndostarDRUGinclude", "suppress": false, "filterType": "include", "term": "Endostar", "custom": false, "facet": "DRUG", "alias": "Endostar"}, {"priority": 1, "compositeKey": "Vincristine sulfateDRUGinclude", "suppress": false, "filterType": "include", "term": "Vincristine sulfate", "custom": false, "facet": "DRUG", "alias": "Vincristine sulfate"}, {"priority": 0, "compositeKey": "Vinca AlkaloidDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Vinca Alkaloid", "custom": false, "facet": "DRUGCLASS", "alias": "Vinca Alkaloid", "generatedByTerm": "Vincristine sulfate"}, {"priority": 0, "compositeKey": "ChemotherapyDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Chemotherapy", "custom": false, "facet": "DRUGCLASS", "alias": "Chemotherapy", "generatedByTerm": "Cyclophosphamide"}, {"priority": 1, "compositeKey": "CyclophosphamideDRUGinclude", "suppress": false, "filterType": "include", "term": "Cyclophosphamide", "custom": false, "facet": "DRUG", "alias": "Cyclophosphamide"}, {"priority": 0, "compositeKey": "Alkylating DrugDRUGCLASSinclude", "suppress": false, "generatedBy": "DRUG", "filterType": "include", "term": "Alkylating Drug", "custom": false, "facet": "DRUGCLASS", "alias": "Alkylating Drug", "generatedByTerm": "Cyclophosphamide"}, {"priority": 1, "compositeKey": "Squamous cell carcinoma of skinCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Squamous cell carcinoma of skin", "custom": false, "facet": "CONDITION", "alias": "Squamous cell carcinoma of skin"}, {"priority": 1, "compositeKey": "Malignant neoplasm of skinCONDITIONexclude", "suppress": false, "filterType": "exclude", "term": "Malignant neoplasm of skin", "custom": false, "facet": "CONDITION", "alias": "Malignant neoplasm of skin"}, {"priority": 1, "compositeKey": "CombinationTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Combination", "custom": false, "facet": "TRIALTYPE", "alias": "Combination"}, {"priority": 1, "compositeKey": "InterventionalTRIALTYPEinclude", "suppress": false, "filterType": "include", "term": "Interventional", "custom": false, "facet": "TRIALTYPE", "alias": "Interventional"}, {"priority": 1, "compositeKey": "RadiationDRUGCLASSexclude", "suppress": false, "filterType": "exclude", "term": "Radiation", "custom": false, "facet": "DRUGCLASS", "alias": "Radiation"}, {"priority": 1, "compositeKey": "VEGFDGENEinclude", "suppress": false, "generatedBy": "GENE", "filterType": "include", "term": "VEGFD", "custom": false, "facet": "GENE", "alias": "VEGFD", "generatedByTerm": "VEGF"}, {"priority": 1, "compositeKey": "PIGFGENEinclude", "suppress": false, "generatedBy": "GENE", "filterType": "include", "term": "PIGF", "custom": false, "facet": "GENE", "alias": "PIGF", "generatedByTerm": "VEGF"}, {"priority": 1, "compositeKey": "VEGFAGENEinclude", "suppress": false, "generatedBy": "GENE", "filterType": "include", "term": "VEGFA", "custom": false, "facet": "GENE", "alias": "VEGFA", "generatedByTerm": "VEGF"}, {"priority": 1, "compositeKey": "VEGFBGENEinclude", "suppress": false, "generatedBy": "GENE", "filterType": "include", "term": "VEGFB", "custom": false, "facet": "GENE", "alias": "VEGFB", "generatedByTerm": "VEGF"}, {"priority": 1, "compositeKey": "VEGFCGENEinclude", "suppress": false, "generatedBy": "GENE", "filterType": "include", "term": "VEGFC", "custom": false, "facet": "GENE", "alias": "VEGFC", "generatedByTerm": "VEGF"}]}
"""  # NOQA

MSH6 = """
{"keywords":[],"gender":["Male","Female"],"studyDesign":null,"link":"http://clinicaltrials.gov/ct2/show/NCT02432963","source":"CTGOV","title":"A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab","overallContact":null,"exclusionCriteria":"Exclusion Criteria: -  Patients may not be receiving any additional investigational agents or radiation    therapy -  Pregnancy: pregnant women are excluded from this study; should a woman become pregnant    or suspect that she is pregnant while participating on the trial, she should inform    her treating physician immediately; women who are pregnant or breastfeeding are    excluded -  Patients with known brain metastasis -  Radiotherapy within 4 weeks prior to entering the study -  Patients with previous exposure to anti-programmed cell death (PD)-1 or    anti-programmed cell death ligand 1 (PDL-1) will not be eligible -  History of allergy to egg proteins -  Patients who have not recovered from adverse events due to agents administered more    than 4 weeks earlier -  Concurrent use of systemic corticosteroids (nasal corticosteroids, inhaled steroids,    adrenal replacement steroids, and topical steroids are allowed) -  History of immunodeficiency or autoimmune disease: patients with a history of    immunodeficiency, including organ grafts and human immunodeficiency virus (HIV), will    not be eligible -  Patients with a history of autoimmune disease will also be excluded, specifically    those with any active autoimmune disease or a condition that requires systemic    corticosteroids; exceptions to this are subjects with vitiligo and type I diabetes    mellitus, who will be permitted to enroll -  Patients with a history of severe immune-mediated adverse reactions with ipilimumab:    this will be defined as any grade 4 toxicity requiring treatment with corticosteroids    (greater than 10 mg/day prednisone or equivalent dose) for greater than 12 weeks -  Patients with a history of cardiac disease are excluded; baseline electrocardiography    and assessment of serum troponin (I) are included the screening exams; subjects in    whom these assays are abnormal (electrocardiogram [EKG] excluding 1st degree bundle    branch block, sinus bradycardia, sinus tachycardia or non-specific T wave changes,    serum troponin >= grade 2) are ineligible -  Non-compliance: if it is the opinion of the investigator that a subject may be unable    to comply with the safety monitoring requirements of the study, they will be excluded      ","armGroups":[{"arm_group_label":"Treatment (p53MVA, pembrolizumab)","arm_group_type":"Experimental","description":"Patients receive pembrolizumab IV over 30 minutes followed by modified vaccinia virus Ankara vaccine expressing p53 SC at least 30 minutes later once in weeks 1, 4, and 7. Patients may receive additional doses of pembrolizumab in weeks 10, 13, 16, and 19, for a maximum of 7 doses if there are no signs of progressive disease. Treatment continues in the absence of disease progression or unacceptable toxicity."}],"exclusionCriteriaPreserved":"Exclusion Criteria:  -  Patients may not be receiving any additional investigational agents or radiation     therapy  -  Pregnancy: pregnant women are excluded from this study; should a woman become pregnant     or suspect that she is pregnant while participating on the trial, she should inform     her treating physician immediately; women who are pregnant or breastfeeding are     excluded  -  Patients with known brain metastasis  -  Radiotherapy within 4 weeks prior to entering the study  -  Patients with previous exposure to anti-programmed cell death (PD)-1 or     anti-programmed cell death ligand 1 (PDL-1) will not be eligible  -  History of allergy to egg proteins  -  Patients who have not recovered from adverse events due to agents administered more     than 4 weeks earlier  -  Concurrent use of systemic corticosteroids (nasal corticosteroids, inhaled steroids,     adrenal replacement steroids, and topical steroids are allowed)  -  History of immunodeficiency or autoimmune disease: patients with a history of     immunodeficiency, including organ grafts and human immunodeficiency virus (HIV), will     not be eligible  -  Patients with a history of autoimmune disease will also be excluded, specifically     those with any active autoimmune disease or a condition that requires systemic     corticosteroids; exceptions to this are subjects with vitiligo and type I diabetes     mellitus, who will be permitted to enroll  -  Patients with a history of severe immune-mediated adverse reactions with ipilimumab:     this will be defined as any grade 4 toxicity requiring treatment with corticosteroids     (greater than 10 mg/day prednisone or equivalent dose) for greater than 12 weeks  -  Patients with a history of cardiac disease are excluded; baseline electrocardiography     and assessment of serum troponin (I) are included the screening exams; subjects in     whom these assays are abnormal (electrocardiogram [EKG] excluding 1st degree bundle     branch block, sinus bradycardia, sinus tachycardia or non-specific T wave changes,     serum troponin >= grade 2) are ineligible  -  Non-compliance: if it is the opinion of the investigator that a subject may be unable     to comply with the safety monitoring requirements of the study, they will be excluded       ","overallContactBackup":null,"studyType":"Interventional","sponsors":[{"lead_sponsor":{"agency":"City of Hope Medical Center","agency_class":"Other"},"collaborator":{"agency":"National Cancer Institute (NCI)","agency_class":"NIH"}}],"briefTitle":"Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy","id":"NCT02432963","summary":"      PRIMARY OBJECTIVES:      I. To determine the safety and tolerability of combined p53MVA vaccine (modified vaccinia      virus Ankara vaccine expressing p53) and pembrolizumab that are well-tolerated in patients      with refractory, tumor protein 53 (p53) over expressing cancer.      SECONDARY OBJECTIVES:      I. To evaluate clinical response and anti-p53 T cell immune responses.      OUTLINE: Patients receive pembrolizumab intravenously (IV) over 30 minutes followed by      modified vaccinia virus Ankara vaccine expressing p53 subcutaneously (SC) at least 30 minutes      later once in weeks 1, 4, and 7.      Patients may receive additional doses of pembrolizumab in weeks 10, 13, 16, and 19, for a      maximum of 7 doses if there are no signs of progressive disease. Treatment continues in the      absence of disease progression or unacceptable toxicity.      After completion of study treatment, patients are followed up periodically.    ","phase":"Phase 1","secondaryOutcomes":[{"measure":"Clinical responses, assessed by the modified Response Evaluation Criteria in Solid Tumors (RECIST)","time_frame":"Up to week 19","description":"Evaluated using immune-related response criteria (irRECIST, irRC)."},{"measure":"T cell reactivity to p53, assessed by flow cytometry","time_frame":"Up to week 19","description":"Immunosuppressive cell types (MDSC, Tregs) and other selected lymphocyte subsets and markers including PD-1, PDL-1 and PDL-2 will be quantified. The Wilcoxon rank-sum test will be used, and are based on residual re-sampling simulations based on historical AUC values (subtracting baseline) and a hypothesized increase in that AUC."}],"briefSummary":"      This phase I trial studies the side effects of vaccine therapy and pembrolizumab in treating      patients with solid tumors that have spread to other places in the body and usually cannot be      cured or controlled with treatment, that have failed prior therapy, and that cannot be      removed by surgery. Vaccines made from a gene-modified virus may help the body build an      effective immune response to kill tumor cells. Monoclonal antibodies, such as pembrolizumab,      may block tumor growth in different ways by targeting certain cells. Giving vaccine therapy      together with pembrolizumab may be a better treatment in patients with solid tumors.    ","primaryOutcomes":[],"synonyms":[],"countries":[{"name":"United States","code":"US"}],"inclusionCriteria":"        Inclusion Criteria: -  Since p53 mutations occur in a wide variety of tumor types, this is a mixed histology    study for incurable tumors; subjects with the following solid tumors are eligible for    screening: non-small cell lung cancer, squamous cell carcinoma of the head and neck,    hepatocellular carcinoma, renal cell carcinoma, melanoma, bladder, soft tissue    sarcoma, triple-negative breast cancer, and colorectal carcinoma displaying    microsatellite instability and pancreatic cancer -  Advanced (unresectable) solid tumors: patients must have failed or been intolerant to    at least one line of standard therapy or refuse standard treatment -  Performance status: patients must have an Eastern Cooperative Oncology Group (ECOG) =<    2 (Karnofsky >= 60%) -  Informed consent: all subjects must have the ability to understand and the willingness    to sign an Institutional Review Board (IRB) approved consent form -  Absolute neutrophil count: >= 1,500/ul -  Platelets >= 100,000/ul -  Hemoglobin level: must be greater than 9 g/dL -  Renal function: calculated or measured creatinine clearance >= 50 ml/min and/or serum    creatinine =< 1.6 mg/dl -  Total bilirubin =< 1.5 x institutional upper limit of normal -  Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 times    institutional upper normal level (AST and ALT =< 5 times institutional upper normal    level, if there is evidence of liver metastasis) -  Confirmed p53 involvement: patients with p53 over-expression by immunohistochemistry    (>= 10% of cells within the tumor staining positive) or those with a p53 mutation as    determined by mutational analysis of tumor tissue will be eligible; patients with    prior exposure to p53-based vaccines will be eligible -  Agreement to use adequate contraception: women of child-bearing potential must use    contraception prior to study entry and for six months after study participation; men    that are sexually active whose partners are women of childbearing age must use condoms        ","enrollment":19,"tags":[{"term":"ERBB2 Loss","facet":"MUTATION","filterType":"include","priority":1,"custom":true,"suppress":false,"manualSuppress":0,"generatedBy":"","generatedByTerm":"","compositeKey":"ERBB2 LossMUTATIONinclude","id":"NCT02432963ERBB2 LossMUTATIONinclude","alias":"ERBB2 Loss"},{"compositeKey":"TP53 AmplificationMUTATIONinclude","term":"TP53 Amplification","facet":"MUTATION","filterType":"include","priority":1,"custom":true,"suppress":false,"manualSuppress":0,"generatedBy":"","generatedByTerm":"","alias":"TP53 Amplification"},{"compositeKey":"Neoplasm of liverCONDITIONinclude","term":"Neoplasm of liver","facet":"CONDITION","filterType":"include","priority":1,"custom":false,"suppress":false,"manualSuppress":0,"generatedBy":"","generatedByTerm":"","alias":"Hepatoma"},{"compositeKey":"mCRC - Metastatic colorectal cancerCONDITIONinclude","term":"mCRC - Metastatic colorectal cancer","facet":"CONDITION","filterType":"include","priority":0,"custom":false,"suppress":false,"manualSuppress":0,"generatedBy":"","generatedByTerm":"","alias":"mCRC - Metastatic colorectal cancer"},{"term":"ERBB2 Copy Number Loss","facet":"MUTATION","filterType":"include","priority":0,"custom":true,"suppress":false,"manualSuppress":0,"generatedBy":"MUTATION","generatedByTerm":"ERBB2 Loss","compositeKey":"ERBB2 Copy Number LossMUTATIONinclude","id":"NCT02432963ERBB2 LossMUTATIONinclude","alias":"ERBB2 Copy Number Loss"},{"facet":"STATUS","term":"Active, not recruiting","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Active, not recruitingSTATUSinclude","alias":"Active, not recruiting"},{"facet":"CONDITION","term":"Neoplasm of rectum","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Neoplasm of rectumCONDITIONinclude","alias":"Colorectal cancer"},{"term":"Neoplasm of colorectum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of colorectumCONDITIONinclude","alias":"Colorectal cancer"},{"term":"Neoplasm of digestive tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of digestive tractCONDITIONinclude","alias":"Neoplasm of digestive tract"},{"term":"Neoplasia","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Sarcoma of soft tissue","compositeKey":"NeoplasiaCONDITIONinclude","alias":"Neoplasia"},{"term":"Neoplasm of intra-abdominal organs","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Neoplasm of intra-abdominal organsCONDITIONinclude","alias":"Abdominal viscus cancer"},{"term":"Malignant neoplastic disease","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Sarcoma of soft tissue","compositeKey":"Malignant neoplastic diseaseCONDITIONinclude","alias":"Cancer"},{"term":"Neoplasm of large intestine","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of large intestineCONDITIONinclude","alias":"Large intestine cancer"},{"facet":"CONDITION","term":"Solid tumor","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Solid tumorCONDITIONinclude","alias":"Solid tumor"},{"term":"Neoplasm of digestive system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of digestive systemCONDITIONinclude","alias":"Digestive system cancer"},{"term":"Neoplasm of digestive organ","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of digestive organCONDITIONinclude","alias":"Digestive organ cancer"},{"term":"Tumour of gastrointestinal tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Tumour of gastrointestinal tractCONDITIONinclude","alias":"Tumour of gastrointestinal tract"},{"term":"Neoplasm of intestinal tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Neoplasm of intestinal tractCONDITIONinclude","alias":"Intestinal cancer"},{"term":"Rectum","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"RectumSITEinclude","alias":"Rectum"},{"facet":"CONDITION","term":"Carcinoma of rectum","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Carcinoma of rectumCONDITIONinclude","alias":"Carcinoma of rectum"},{"term":"Malignant neoplasm of anorectum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Malignant neoplasm of anorectumCONDITIONinclude","alias":"Malignant neoplasm of anorectum"},{"term":"Cancer of intraabdominal organ","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Cancer of intraabdominal organCONDITIONinclude","alias":"Cancer of intraabdominal organ"},{"term":"Malignant tumor of abdomen","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Malignant tumor of abdomenCONDITIONinclude","alias":"Malignant tumor of abdomen"},{"term":"Adenocarcinoma of large intestine","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Adenocarcinoma of large intestineCONDITIONinclude","alias":"Adenocarcinoma of large intestine"},{"term":"Adenocarcinoma","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"AdenocarcinomaCONDITIONinclude","alias":"Unknown primary adenocarcinoma"},{"term":"Cancer of digestive system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Cancer of digestive systemCONDITIONinclude","alias":"Cancer of digestive system"},{"term":"Malignant tumor of pelvis","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of urinary bladder, superficial","compositeKey":"Malignant tumor of pelvisCONDITIONinclude","alias":"Malignant tumor of pelvis"},{"term":"Adenocarcinoma of anorectum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Adenocarcinoma of anorectumCONDITIONinclude","alias":"Adenocarcinoma of anorectum"},{"term":"Malignant neoplasm of gastrointestinal tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Malignant neoplasm of gastrointestinal tractCONDITIONinclude","alias":"Malignant neoplasm of gastrointestinal tract"},{"term":"Rectal cancer","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Rectal cancerCONDITIONinclude","alias":"Rectal cancer"},{"term":"Adenocarcinoma of pelvis","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Adenocarcinoma of pelvisCONDITIONinclude","alias":"Adenocarcinoma of pelvis"},{"term":"Malignant tumour of digestive organ","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of rectum","compositeKey":"Malignant tumour of digestive organCONDITIONinclude","alias":"Malignant tumour of digestive organ"},{"facet":"CONDITION","term":"Carcinoma of urinary bladder, superficial","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Carcinoma of urinary bladder, superficialCONDITIONinclude","alias":"Superficial Bladder Cancer"},{"term":"Tumour of urinary bladder","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of urinary bladder, superficial","compositeKey":"Tumour of urinary bladderCONDITIONinclude","alias":"Bladder cancer"},{"term":"Neoplasm of urinary tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of urinary bladder, superficial","compositeKey":"Neoplasm of urinary tractCONDITIONinclude","alias":"Urinary tract cancer"},{"term":"Malignant tumor of urinary system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Malignant tumor of urinary systemCONDITIONinclude","alias":"Malignant tumor of urinary system"},{"term":"Malignant tumour of urinary tract proper","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of urinary bladder, superficial","compositeKey":"Malignant tumour of urinary tract properCONDITIONinclude","alias":"Malignant tumour of urinary tract proper"},{"term":"Malignant neoplasm of genitourinary organ","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Malignant neoplasm of genitourinary organCONDITIONinclude","alias":"Malignant neoplasm of genitourinary organ"},{"term":"Neoplasm of urinary system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Neoplasm of urinary systemCONDITIONinclude","alias":"Genitourinary cancer"},{"term":"Bladder","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Carcinoma of urinary bladder, superficial","compositeKey":"BladderSITEinclude","alias":"Bladder"},{"facet":"CONDITION","term":"CA - Carcinoma of breast","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"CA - Carcinoma of breastCONDITIONinclude","alias":"CA - Carcinoma of breast"},{"term":"Neoplasm of breast","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":1,"generatedBy":"CONDITION","generatedByTerm":"Triple Negative Breast Cancer","compositeKey":"Neoplasm of breastCONDITIONinclude","alias":"Breast cancer"},{"term":"Malignant tumor of breast","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"CA - Carcinoma of breast","compositeKey":"Malignant tumor of breastCONDITIONinclude","alias":"Metastatic breast cancer"},{"term":"Mammary gland","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"CA - Carcinoma of breast","compositeKey":"Mammary glandSITEinclude","alias":"Mammary gland"},{"facet":"CONDITION","term":"Neoplasm of lung","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Neoplasm of lungCONDITIONinclude","alias":"Lung cancer"},{"term":"Neoplasm of respiratory tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Neoplasm of respiratory tractCONDITIONinclude","alias":"Respiratory tract cancer"},{"term":"Neoplasm of respiratory system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Neoplasm of respiratory systemCONDITIONinclude","alias":"respiratory system cancer"},{"term":"Lung","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"LungSITEinclude","alias":"Lung"},{"facet":"TRIALTYPE","term":"Combination","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"CombinationTRIALTYPEinclude","alias":"Combination"},{"facet":"TRIALTYPE","term":"Interventional","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"InterventionalTRIALTYPEinclude","alias":"Interventional"},{"facet":"CONDITION","term":"Secondary malignant neoplastic disease","suppress":false,"custom":false,"priority":0,"filterType":"exclude","compositeKey":"Secondary malignant neoplastic diseaseCONDITIONexclude","alias":"Metastases"},{"facet":"CONDITION","term":"Type 1 diabetes mellitus","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Type 1 diabetes mellitusCONDITIONexclude","alias":"Type 1 diabetes mellitus"},{"facet":"CONDITION","term":"HIV - Human immunodeficiency virus infection","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"HIV - Human immunodeficiency virus infectionCONDITIONexclude","alias":"HIV"},{"facet":"DRUGCLASS","term":"Radiation","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"RadiationDRUGCLASSexclude","alias":"Radiation"},{"facet":"DRUG","term":"p53MVA","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"p53MVADRUGinclude","alias":"p53MVA"},{"facet":"DRUGCLASS","term":"Vaccine","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"VaccineDRUGCLASSinclude","alias":"Vaccine"},{"facet":"CONDITION","term":"Sarcoma","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"SarcomaCONDITIONinclude","alias":"Sarcoma"},{"facet":"CONDITION","term":"Squamous cell carcinoma","suppress":false,"custom":false,"priority":0,"filterType":"include","compositeKey":"Squamous cell carcinomaCONDITIONinclude","alias":"Squamous cell carcinoma"},{"facet":"CONDITION","term":"Carcinoma, NOS","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Carcinoma, NOSCONDITIONinclude","alias":"carcinoma of unknown primary site"},{"facet":"MUTATION","term":"ER Negative","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"ER NegativeMUTATIONinclude","alias":"ER Negative"},{"facet":"MUTATION","term":"Microsatellite instability","suppress":false,"custom":false,"priority":2,"filterType":"include","compositeKey":"Microsatellite instabilityMUTATIONinclude","alias":"Microsatellite instability"},{"term":"MLH1","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":0,"generatedBy":"MUTATION","generatedByTerm":"Microsatellite instability","compositeKey":"MLH1GENEinclude","alias":"MLH1"},{"term":"PMS2","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":0,"generatedBy":"MUTATION","generatedByTerm":"Microsatellite instability","compositeKey":"PMS2GENEinclude","alias":"MLH4"},{"term":"MSH6","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":0,"generatedBy":"MUTATION","generatedByTerm":"Microsatellite instability","compositeKey":"MSH6GENEinclude","alias":"MSH6"},{"term":"MSH2","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":0,"generatedBy":"MUTATION","generatedByTerm":"Microsatellite instability","compositeKey":"MSH2GENEinclude","alias":"MSH2"},{"facet":"CONDITION","term":"Triple Negative Breast Cancer","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Triple Negative Breast CancerCONDITIONinclude","alias":"Triple Negative Breast Cancer"},{"term":"ER/PR negative","filterType":"include","custom":false,"suppress":false,"facet":"MUTATION","priority":1,"generatedBy":"CONDITION","generatedByTerm":"Triple Negative Breast Cancer","compositeKey":"ER/PR negativeMUTATIONinclude","alias":"ER/PR negative"},{"term":"Wild-Type ERBB2","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":1,"generatedBy":"CONDITION","generatedByTerm":"Triple Negative Breast Cancer","compositeKey":"Wild-Type ERBB2GENEinclude","alias":"Wild-Type ERBB2"},{"facet":"CONDITION","term":"Head and Neck Squamous Cell Carcinoma","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Head and Neck Squamous Cell CarcinomaCONDITIONinclude","alias":"HNSCC-Head and Neck Squamous Cell Carcinoma"},{"term":"Malignant tumor of head and neck","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Head and Neck Squamous Cell Carcinoma","compositeKey":"Malignant tumor of head and neckCONDITIONinclude","alias":"Malignant tumor of head and neck"},{"term":"Malignant neoplasm of skin head and neck","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Head and Neck Squamous Cell Carcinoma","compositeKey":"Malignant neoplasm of skin head and neckCONDITIONinclude","alias":"Malignant neoplasm of skin head and neck"},{"term":"Neoplasm of head and neck","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Head and Neck Squamous Cell Carcinoma","compositeKey":"Neoplasm of head and neckCONDITIONinclude","alias":"Neoplasm of head and neck"},{"term":"Head and neck","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Head and Neck Squamous Cell Carcinoma","compositeKey":"Head and neckSITEinclude","alias":"Head and neck"},{"facet":"CONDITION","term":"squamous","suppress":false,"custom":false,"priority":0,"filterType":"include","compositeKey":"squamousCONDITIONinclude","alias":"squamous"},{"facet":"MEDICALGROUP","term":"National Cancer Institute","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"National Cancer InstituteMEDICALGROUPinclude","alias":"National Cancer Institute"},{"facet":"MEDICALGROUP","term":"National Institutes of Health","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"National Institutes of HealthMEDICALGROUPinclude","alias":"National Institutes of Health"},{"facet":"DRUG","term":"Pembrolizumab","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"PembrolizumabDRUGinclude","alias":"Pembrolizumab"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"JAK2 Loss","filterType":"exclude","facet":"MUTATION","compositeKey":"JAK2 LossMUTATIONexclude","alias":"JAK2 Loss"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"JAK1 Loss","filterType":"exclude","facet":"MUTATION","compositeKey":"JAK1 LossMUTATIONexclude","alias":"JAK1 Loss"},{"term":"Immunotherapy","filterType":"include","custom":false,"suppress":false,"facet":"DRUGCLASS","priority":0,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","compositeKey":"ImmunotherapyDRUGCLASSinclude","alias":"Immunotherapy"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"PDCD1 inhibitor","filterType":"include","facet":"DRUGCLASS","compositeKey":"PDCD1 inhibitorDRUGCLASSinclude","alias":"PDCD1 inhibitor"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"CD274","filterType":"include","facet":"GENE","compositeKey":"CD274GENEinclude","alias":"PD-L1"},{"term":"PDCD1","filterType":"include","custom":false,"suppress":false,"facet":"GENE","priority":0,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","compositeKey":"PDCD1GENEinclude","alias":"PD-1"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"PDCD1LG2","filterType":"include","facet":"GENE","compositeKey":"PDCD1LG2GENEinclude","alias":"PD-L2"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"Ipilimumab resistance","filterType":"include","facet":"RESISTANCE","compositeKey":"Ipilimumab resistanceRESISTANCEinclude","alias":"Ipilimumab resistance"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"JAK1 Q503*","filterType":"exclude","facet":"MUTATION","compositeKey":"JAK1 Q503*MUTATIONexclude","alias":"JAK1 Q503*"},{"facet":"DRUGCLASS","term":"antibody drug","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"antibody drugDRUGCLASSinclude","alias":"monoclonal antibody"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"Neoadjuvant","filterType":"include","facet":"DRUGCLASS","compositeKey":"NeoadjuvantDRUGCLASSinclude","alias":"Neoadjuvant"},{"custom":false,"suppress":false,"generatedBy":"DRUG","generatedByTerm":"Pembrolizumab","priority":0,"term":"Adjuvant","filterType":"include","facet":"DRUGCLASS","compositeKey":"AdjuvantDRUGCLASSinclude","alias":"Adjuvant"},{"facet":"CONDITION","term":"MM - Malignant melanoma of skin","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"MM - Malignant melanoma of skinCONDITIONinclude","alias":"Melanoma"},{"term":"Neoplasm of integumentary system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"MM - Malignant melanoma of skin","compositeKey":"Neoplasm of integumentary systemCONDITIONinclude","alias":"integumentary system cancer"},{"term":"Melanocytic neoplasm","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"MM - Malignant melanoma of skin","compositeKey":"Melanocytic neoplasmCONDITIONinclude","alias":"Melanocytic neoplasm"},{"term":"Malignant neoplasm of skin","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"MM - Malignant melanoma of skin","compositeKey":"Malignant neoplasm of skinCONDITIONinclude","alias":"Malignant neoplasm of skin"},{"term":"Malignant tumour of soft tissue","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Sarcoma of soft tissue","compositeKey":"Malignant tumour of soft tissueCONDITIONinclude","alias":"Malignant tumour of soft tissue"},{"term":"Malignant melanoma","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"MM - Malignant melanoma of skin","compositeKey":"Malignant melanomaCONDITIONinclude","alias":"Malignant melanoma"},{"term":"Melanocytic tumor of skin","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"MM - Malignant melanoma of skin","compositeKey":"Melanocytic tumor of skinCONDITIONinclude","alias":"Melanocytic tumor of skin"},{"term":"Neoplasm of soft tissue","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Sarcoma of soft tissue","compositeKey":"Neoplasm of soft tissueCONDITIONinclude","alias":"Soft tissues cancer"},{"facet":"PHASE","term":"Phase 1","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Phase 1PHASEinclude","alias":"Phase 1"},{"facet":"CONDITION","term":"Secondary malignant neoplasm of cerebral ventricle","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Secondary malignant neoplasm of cerebral ventricleCONDITIONexclude","alias":"Secondary malignant neoplasm of cerebral ventricle"},{"facet":"CONDITION","term":"Secondary malignant neoplasm of cerebral meninges","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Secondary malignant neoplasm of cerebral meningesCONDITIONexclude","alias":"Secondary malignant neoplasm of cerebral meninges"},{"facet":"CONDITION","term":"Secondary cancer of brain","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Secondary cancer of brainCONDITIONexclude","alias":"Brain metastases"},{"facet":"FINDING","term":"Heart rate slow","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Heart rate slowFINDINGexclude","alias":"Heart rate slow"},{"facet":"FINDING","term":"Tachycardia - pulse","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Tachycardia - pulseFINDINGexclude","alias":"Tachycardia"},{"facet":"FINDING","term":"Normal breast feeding","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Normal breast feedingFINDINGexclude","alias":"Breast feeding"},{"facet":"FINDING","term":"Pregnancy confirmed","suppress":false,"custom":false,"priority":1,"filterType":"exclude","compositeKey":"Pregnancy confirmedFINDINGexclude","alias":"Pregnant"},{"facet":"CONDITION","term":"Grawitz tumor","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Grawitz tumorCONDITIONinclude","alias":"RCC - Renal Cell Carcinoma"},{"term":"Renal tumour","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Renal tumourCONDITIONinclude","alias":"Kidney cancer"},{"term":"Primary malignant neoplasm of urinary system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Primary malignant neoplasm of urinary systemCONDITIONinclude","alias":"Primary malignant neoplasm of urinary system"},{"term":"Primary malignant neoplasm of kidney","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Primary malignant neoplasm of kidneyCONDITIONinclude","alias":"Primary malignant neoplasm of kidney"},{"term":"Primary malignant neoplasm of intra-abdominal organs","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Primary malignant neoplasm of intra-abdominal organsCONDITIONinclude","alias":"Primary malignant neoplasm of intra-abdominal organs"},{"term":"Primary malignant neoplasm of retroperitoneum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Primary malignant neoplasm of retroperitoneumCONDITIONinclude","alias":"Primary malignant neoplasm of retroperitoneum"},{"term":"Malignant neoplasm of retroperitoneum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Malignant neoplasm of retroperitoneumCONDITIONinclude","alias":"Malignant neoplasm of retroperitoneum"},{"term":"Malignant neoplasm of kidney parenchyma","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Malignant neoplasm of kidney parenchymaCONDITIONinclude","alias":"Malignant neoplasm of kidney parenchyma"},{"term":"Tumour of retroperitoneum","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Tumour of retroperitoneumCONDITIONinclude","alias":"Retroperitoneum cancer"},{"term":"Renal","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"RenalSITEinclude","alias":"Renal"},{"term":"Renal parenchyma","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Grawitz tumor","compositeKey":"Renal parenchymaSITEinclude","alias":"Renal parenchyma"},{"facet":"CONDITION","term":"Hepatocarcinoma","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"HepatocarcinomaCONDITIONinclude","alias":"HCC - Hepatocellular carcinoma"},{"term":"Malignant neoplasm of liver","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Hepatocarcinoma","compositeKey":"Malignant neoplasm of liverCONDITIONinclude","alias":"Malignant neoplasm of liver"},{"term":"Liver","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Hepatocarcinoma","compositeKey":"LiverSITEinclude","alias":"Liver"},{"facet":"CONDITION","term":"Non-small cell lung cancer","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Non-small cell lung cancerCONDITIONinclude","alias":"NSCLC - Non-small cell lung cancer"},{"term":"Primary malignant neoplasm of respiratory tract","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Primary malignant neoplasm of respiratory tractCONDITIONinclude","alias":"Primary malignant neoplasm of respiratory tract"},{"term":"Carcinoma of lung","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Carcinoma of lungCONDITIONinclude","alias":"Carcinoma of lung"},{"term":"Primary malignant neoplasm of lung","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Primary malignant neoplasm of lungCONDITIONinclude","alias":"Primary malignant neoplasm of lung"},{"term":"Cancer of respiratory system","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Cancer of respiratory systemCONDITIONinclude","alias":"Cancer of respiratory system"},{"term":"Primary malignant neoplasm of intrathoracic organs","filterType":"include","custom":false,"suppress":false,"facet":"CONDITION","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Non-small cell lung cancer","compositeKey":"Primary malignant neoplasm of intrathoracic organsCONDITIONinclude","alias":"Primary malignant neoplasm of intrathoracic organs"},{"facet":"CONDITION","term":"Sarcoma of soft tissue","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"Sarcoma of soft tissueCONDITIONinclude","alias":"Soft tissue sarcoma"},{"term":"Soft tissues","filterType":"include","custom":false,"suppress":false,"facet":"SITE","priority":0,"generatedBy":"CONDITION","generatedByTerm":"Sarcoma of soft tissue","compositeKey":"Soft tissuesSITEinclude","alias":"Soft tissues"},{"facet":"GENE","term":"TP53","suppress":false,"custom":false,"priority":1,"filterType":"include","compositeKey":"TP53GENEinclude","alias":"TP53"},{"term":"Hormone receptor negative neoplasm","facet":"CONDITION","priority":1,"filterType":"include","suppress":false,"custom":false,"compositeKey":"Hormone receptor negative neoplasmCONDITIONinclude","alias":"Hormone receptor negative neoplasm"}],"overallOfficial":{"last_name":"Vincent Chung","role":"Principal Investigator","affiliation":"City of Hope Medical Center"},"interventions":[{"intervention_type":"Other","intervention_name":"Laboratory Biomarker Analysis","description":"Correlative studies","arm_group_label":"Treatment (p53MVA, pembrolizumab)"},{"intervention_type":"Biological","intervention_name":"Modified Vaccinia Virus Ankara Vaccine Expressing p53","description":"Given SC","arm_group_label":"Treatment (p53MVA, pembrolizumab)","other_name":["MVA-p53 Vaccine","MVAp53 Vaccine"]},{"intervention_type":"Biological","intervention_name":"Pembrolizumab","description":"Given IV","arm_group_label":"Treatment (p53MVA, pembrolizumab)","other_name":["Keytruda","Lambrolizumab","MK-3475","SCH 900475"]}],"maxAge":10000,"minAge":18,"locations":[{"id":"cityofhopemedicalcenter_duarte_california_us_91010","name":"City Of Hope Medical Center","city":"Duarte","state":"California","country":"United States","zip":"91010","location":{"type":"Point","coordinates":[-117.977,34.139]},"geo":{"lat":34.139,"lon":-117.977},"status":"Active, not recruiting"}],"inclusionCriteriaPreserved":"         Inclusion Criteria:  -  Since p53 mutations occur in a wide variety of tumor types, this is a mixed histology     study for incurable tumors; subjects with the following solid tumors are eligible for     screening: non-small cell lung cancer, squamous cell carcinoma of the head and neck,     hepatocellular carcinoma, renal cell carcinoma, melanoma, bladder, soft tissue     sarcoma, triple-negative breast cancer, and colorectal carcinoma displaying     microsatellite instability and pancreatic cancer  -  Advanced (unresectable) solid tumors: patients must have failed or been intolerant to     at least one line of standard therapy or refuse standard treatment  -  Performance status: patients must have an Eastern Cooperative Oncology Group (ECOG) =<     2 (Karnofsky >= 60%)  -  Informed consent: all subjects must have the ability to understand and the willingness     to sign an Institutional Review Board (IRB) approved consent form  -  Absolute neutrophil count: >= 1,500/ul  -  Platelets >= 100,000/ul  -  Hemoglobin level: must be greater than 9 g/dL  -  Renal function: calculated or measured creatinine clearance >= 50 ml/min and/or serum     creatinine =< 1.6 mg/dl  -  Total bilirubin =< 1.5 x institutional upper limit of normal  -  Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 times     institutional upper normal level (AST and ALT =< 5 times institutional upper normal     level, if there is evidence of liver metastasis)  -  Confirmed p53 involvement: patients with p53 over-expression by immunohistochemistry     (>= 10% of cells within the tumor staining positive) or those with a p53 mutation as     determined by mutational analysis of tumor tissue will be eligible; patients with     prior exposure to p53-based vaccines will be eligible  -  Agreement to use adequate contraception: women of child-bearing potential must use     contraception prior to study entry and for six months after study participation; men     that are sexually active whose partners are women of childbearing age must use condoms         ","conditions":["Adult Solid Neoplasm","Bladder Carcinoma","Colon Carcinoma","Estrogen Receptor Negative","Head and Neck Squamous Cell Carcinoma","Hepatocellular Carcinoma","HER2/Neu Negative","Melanoma","Non-Small Cell Lung Carcinoma","Pancreatic Carcinoma","Progesterone Receptor Negative","Rectal Carcinoma","Renal Cell Carcinoma","Soft Tissue Sarcoma","Triple-Negative Breast Carcinoma","TP53 Gene Mutation","Unresectable Solid Neoplasm"],"startDate":"November 2015","status":"Active, not recruiting","molecularAlterations":[{"term":"ERBB2 Loss","alias":"ERBB2 Loss"},{"term":"TP53 Amplification","alias":"TP53 Amplification"},{"term":"ER Negative","alias":"ER Negative"},{"term":"Microsatellite instability","alias":"Microsatellite instability"},{"term":"ER/PR negative","alias":"ER/PR negative"},{"term":"Wild-Type ERBB2","alias":"Wild-Type ERBB2"},{"term":"TP53","alias":"TP53"}]}
"""

PHENOTYPE2 = json.loads(phenotype2, strict=False)  # control character


def convert(dictionary):
    return namedtuple('GenericDict', dictionary.keys())(**dictionary)


def test_convert_association():
    # convert returns a generator
    evidences = list(molecularmatch_trials.convert(EVIDENCE))
    evidence = convert(evidences[0])
    association = convert(evidence.association)
    assert association.evidence_label == 'C'


def test_convert_association2():
    # convert returns a generator
    association = {}
    evidence = {'phase': 'Phase 3'}
    association = el.evidence_label(evidence['phase'],
         association, na=False)

    assert association['evidence_label'] == 'B'


def test_convert_phenotype():
    # convert returns a generator
    evidences = list(molecularmatch_trials.convert(PHENOTYPE))
    evidence = convert(evidences[0])
    association = convert(evidence.association)
    assert association.phenotype['description'], \
        'association.phenotype.description empty'
    assert association.phenotype['description'] == 'Tumour of fallopian tube'


def test_convert_phenotype2():
    # convert returns a generator
    evidences = list(molecularmatch_trials.convert(PHENOTYPE2))
    evidence = convert(evidences[0])
    association = convert(evidence.association)
    assert association.phenotype['description'], \
        'association.phenotype.description empty'
    assert association.phenotype['description'] == 'Malignant lymphoma'


def test_convert_MSH6():
    msh6 = json.loads(MSH6)
    print '\n{}'.format(msh6['title'])
    print 'unfiltered:'
    for t in msh6['tags']:
        if t['facet'] == 'GENE':
            print t['term'], '\t', t.get('generatedBy', None), '\t',  t.get('generatedByTerm', None)
    print 'filtered:'
    for t in msh6['tags']:
        if (t['facet'] == 'GENE' and t['filterType'] == 'include' and not t['suppress']):  # noqa
            generatedByTerm = t.get('generatedByTerm', None)
            if generatedByTerm == '':
                generatedByTerm = None
            if generatedByTerm:
                continue
            print t['term'], '\t', t.get('generatedBy', None), '\t',  t.get('generatedByTerm', None)
